Sorrento Therapeutics Inc (NASDAQ:SRNE)

5.95
Delayed Data
As of Nov 26
 -0.02 / -0.34%
Today’s Change
5.70
Today|||52-Week Range
17.25
-12.82%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 22.50, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +278.15% increase from the last price of 5.95.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$7.8M
Reporting Date
Nov 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.92%
 
 
 
 
 
 
Growthannually 26.92%
 
 
 
 
 
 

Sales

Growthquarterly -7.04%
 
 
 
 
 
 
Growthannually 7.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.